- Home
- GWH vs CRIS Comparison
GWH vs CRIS Comparison
Compare GWH & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- CRIS
- Stock Information
- Founded
- GWH 2011
- CRIS 2000
- Country
- GWH United States
- CRIS United States
- Employees
- GWH N/A
- CRIS N/A
- Industry
- GWH Industrial Machinery/Components
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GWH Miscellaneous
- CRIS Health Care
- Exchange
- GWH Nasdaq
- CRIS Nasdaq
- Market Cap
- GWH 25.3M
- CRIS 22.9M
- IPO Year
- GWH N/A
- CRIS 2000
- Fundamental
- Price
- GWH $1.57
- CRIS $1.72
- Analyst Decision
- GWH Hold
- CRIS Strong Buy
- Analyst Count
- GWH 4
- CRIS 2
- Target Price
- GWH $2.67
- CRIS $16.50
- AVG Volume (30 Days)
- GWH 155.0K
- CRIS 75.0K
- Earning Date
- GWH 11-12-2025
- CRIS 11-13-2025
- Dividend Yield
- GWH N/A
- CRIS N/A
- EPS Growth
- GWH N/A
- CRIS N/A
- EPS
- GWH N/A
- CRIS N/A
- Revenue
- GWH $6,166,000.00
- CRIS $11,405,000.00
- Revenue This Year
- GWH $131.04
- CRIS $2.72
- Revenue Next Year
- GWH $76.74
- CRIS $8.27
- P/E Ratio
- GWH N/A
- CRIS N/A
- Revenue Growth
- GWH N/A
- CRIS 12.24
- 52 Week Low
- GWH $0.76
- CRIS $1.02
- 52 Week High
- GWH $10.12
- CRIS $6.44
- Technical
- Relative Strength Index (RSI)
- GWH 53.02
- CRIS 49.68
- Support Level
- GWH $1.36
- CRIS $1.63
- Resistance Level
- GWH $1.75
- CRIS $1.95
- Average True Range (ATR)
- GWH 0.13
- CRIS 0.15
- MACD
- GWH 0.03
- CRIS 0.00
- Stochastic Oscillator
- GWH 66.04
- CRIS 28.13
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.